277 related articles for article (PubMed ID: 7725263)
1. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
Ryss ES; Fishzon-Ryss IuI
Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
[No Abstract] [Full Text] [Related]
2. [Prokinetic drugs].
Hellström P
Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
[TBL] [Abstract][Full Text] [Related]
3. Cisapride: its use in children.
Newell SJ
Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic-obstructive upper abdominal complaints. Outlook. Further hypothetical indications].
Fortschr Med Suppl; 1990; 87():15-6. PubMed ID: 2190899
[No Abstract] [Full Text] [Related]
5. Cisapride, a drug for long-term treatment?
Harvengt C
Acta Gastroenterol Belg; 1990; 53(4):369-71. PubMed ID: 2096582
[No Abstract] [Full Text] [Related]
6. Cisapride.
Menezes O
Aust Nurses J; 1991 Oct; 21(4):27. PubMed ID: 1750810
[No Abstract] [Full Text] [Related]
7. Use of prokinetic agents in special populations.
Horn JR
Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828
[TBL] [Abstract][Full Text] [Related]
8. Cisapride.
Molinari F; Farrington E
Pediatr Nurs; 1994; 20(2):202-3. PubMed ID: 8159508
[No Abstract] [Full Text] [Related]
9. Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients.
Carone R; Vercelli D; Bertapelle P
Paraplegia; 1993 Feb; 31(2):125-7. PubMed ID: 8446457
[TBL] [Abstract][Full Text] [Related]
10. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology.
McCallum RW
Am J Gastroenterol; 1991 Feb; 86(2):135-49. PubMed ID: 1992624
[No Abstract] [Full Text] [Related]
11. [Prokinetic drugs in digestive disorders].
Carella G; Marra L
Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
[TBL] [Abstract][Full Text] [Related]
12. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
[TBL] [Abstract][Full Text] [Related]
13. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
Reyntjens A; Verlinden M; Schuermans V
Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
[No Abstract] [Full Text] [Related]
14. The current status of gastric prokinetic drugs.
Schapira M; Henrion J; Heller FR
Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
[TBL] [Abstract][Full Text] [Related]
15. [A new concept in the treatment of gastrointestinal diseases--Propulsin. Workshop, Beerse, Belgium, 16 June 1989].
Internist (Berl); 1989 Sep; 30(9 Suppl):1-15. PubMed ID: 2635703
[No Abstract] [Full Text] [Related]
16. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
Hatlebakk JG; Berstad A
Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
[TBL] [Abstract][Full Text] [Related]
17. [A drive substance for the motor in digestion. Introduction].
Demling L
Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358
[No Abstract] [Full Text] [Related]
18. [What is assured in therapy of gastrointestinal diseases with drugs acting on motility?].
Müller-Lissner S; Klauser A
Internist (Berl); 1989 Dec; 30(12):797-804. PubMed ID: 2695489
[No Abstract] [Full Text] [Related]
19. [Functional disorders of the digestive tract and possibilities of therapy with Prepulside (cisapride)].
Hep A; Prásek J; Dítĕ P
Vnitr Lek; 1995 Mar; 41(3):199-203. PubMed ID: 7762181
[TBL] [Abstract][Full Text] [Related]
20. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride].
Van Nueten JM; Schuurkes JA
J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
